<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>§ 306-6 Schedule I. | Menominee Indian Tribe of Wisconsin Law Library</title>
    <link rel="shortcut icon" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/nsn/menominee/legislature/code/II/306/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/nsn/menominee/legislature/code/II/306/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/nsn/menominee/legislature/code" data-document="href"/>
    <meta itemprop="order" content="|II|306|1|II|306-6|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="doc-num" content="306-6"/>
    <meta itemprop="ref-doc" content="Code of the Menominee Indian Tribe" data-document=""/>
    <meta itemprop="ref-path" content="II|§306-6" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/nsn/menominee/legislature/code/II/306-6"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="§ 306-6 Schedule I. | Menominee Indian Tribe of Wisconsin Law Library"/>
    <meta property="og:image" content="/us/nsn/menominee/legislature/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#071346"/>
    <meta name="apple-mobile-web-app-title" content="Menominee Indian Tribe of Wisconsin Law Library"/>
    <meta name="theme-color" content="#071346"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/safari-pinned-tab.svg" color="#071346"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/nsn/menominee/legislature/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/nsn/menominee/legislature/_document/v2/fonts/ananda/ananda.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/nsn/menominee/legislature/_document/v2/fonts/roboto-condensed/roboto-condensed.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/nsn/menominee/legislature/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/nsn/menominee/legislature/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/nsn/menominee/legislature/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/nsn/menominee/legislature/code/II/306/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/nsn/menominee/legislature/code/II/306/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__menominee-nsn">
      <header id="section__header" class="ns__document__menominee-nsn">
        <div id="section__header__inner" class="ns__document__menominee-nsn">
          <div id="area__logo" class="ns__document__menominee-nsn">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/nsn/menominee/legislature/_document/v2/images/logo/logo.png" srcset="/us/nsn/menominee/legislature/_document/v2/images/logo/logo.png 1x, /us/nsn/menominee/legislature/_document/v2/images/logo/logo@2x.png 2x, /us/nsn/menominee/legislature/_document/v2/images/logo/logo@3x.png 3x" alt="Law Library of the Menominee Indian Tribe logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__menominee-nsn">
            <span class="h__library-title">Menominee Indian Tribe of Wisconsin Law Library</span>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__menominee-nsn">
        <div id="section__content__inner" class="ns__document__menominee-nsn">
          <section id="area__breadcrumbs" class="ns__document__menominee-nsn" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Menominee Indian Tribe of Wisconsin Law Library">Menominee Indian Tribe of Wisconsin Law Library</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/nsn/menominee/legislature/code" title="Code of the Menominee Indian Tribe">Code of the Menominee Indian Tribe</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe|II" data-search-heading="">
                  <a href="/us/nsn/menominee/legislature/code/II" title="Part II General Legislation">Part II General Legislation</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe|II|306" data-search-heading="">
                  <a href="/us/nsn/menominee/legislature/code/II/306" title="Chapter 306 DRUGS AND DRUG PARAPHERNALIA">Chapter 306 DRUGS AND DRUG PARAPHERNALIA</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe|II|306|1" data-search-heading="">
                  <a href="/us/nsn/menominee/legislature/code/II/306/1" title="Part 1 Controlled Substances">Part 1 Controlled Substances</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe|II|306|1|II" data-search-heading="">
                  <a href="/us/nsn/menominee/legislature/code/II/306/1/II" title="Article II Provisions for Scheduling; Schedules I, II, III, IV and V">Article II Provisions for Scheduling; Schedules I, II, III, IV and V</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe|II|306|1|II|306-6" data-search-heading="">
                  <span title="§ 306-6 Schedule I.">§ 306-6 Schedule I.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__menominee-nsn">
            <div class="h__document-title">Code of the Menominee Indian Tribe</div>
            <article class="content" role="document" data-ref-path="II|§306-6">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/nsn/menominee/legislature/code/II/306-6">§ 306-6 Schedule I.</h1>
                <p>Unless specifically excepted by tribal regulation or unless listed in another schedule, any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, are listed in Schedule I:</p>
                <p class="text-indent-1 "><span class="level-num" id="A.">A.</span> Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation:</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(1)">(1)</span> Acetyl-alpha-methylfentanyl	[N-(1-[1-methyl-2-phenethyl)-4-piperidinyl)-N-phenylacetamide].</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(2)">(2)</span> Acetylmethadol.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(3)">(3)</span> Allylprodine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(4)">(4)</span> Alphacetylmethadol	(except	levo-alphacetylmethadol,	also	known	as	levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM).</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(5)">(5)</span> Alphameprodine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(6)">(6)</span> Alphamethadol.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(7)">(7)</span> Alpha-methylfentanyl [N-(1-[alpha-methyl-beta-phenyl]ethyl-4-piperidyl) propiona- nilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine].</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(8)">(8)</span> Alpha-methylthiofentanyl	[N-(1-methyl-2-[2-thienyl]ethyl-4-piperidinyl)-N-phenyl-propanamide].</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(9)">(9)</span> Benzethidine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(10)">(10)</span> Betacetylmethadol.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(11)">(11)</span> Beta-hydroxyfentanyl [N-(1-[2-hydroxy-2-phenethyl]-4-piperidinyl)-N-phenyl- propanamide].</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(12)">(12)</span> Beta-hydroxy-3-methylfentanyl [other name: N-(1-[2-hydroxy-2-phenethyl]-3-methyl-4-piperidinyl)-N-phenylpropanamide].</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(13)">(13)</span> Betameprodine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(14)">(14)</span> Betamethadol.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(15)">(15)</span> Betaprodine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(16)">(16)</span> Clonitazene.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(17)">(17)</span> Dextromoramide.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(18)">(18)</span> Diampromide.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(19)">(19)</span> Diethylthiambutene.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(20)">(20)</span> Difenoxin.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(21)">(21)</span> Dimenoxadol.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(22)">(22)</span> Dimepheptanol.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(23)">(23)</span> Dimethylthiambutene.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(24)">(24)</span> Dioxaphetyl butyrate.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(25)">(25)</span> Dipipanone.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(26)">(26)</span> Ethylmethylthiambutene.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(27)">(27)</span> Etonitazene.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(28)">(28)</span> Etoxeridine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(29)">(29)</span> Furethidine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(30)">(30)</span> Hydroxypethidine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(31)">(31)</span> Ketobemidone.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(32)">(32)</span> Levomoramide.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(33)">(33)</span> Levophenacylmorphan.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(34)">(34)</span> 3-Methylfentanyl [N-(3-methyl-1-[2-phenylethyl]-4-piperidyl)-N-phenylpro- panamide].</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(35)">(35)</span> 3-methylthiofentanyl [N-(3-methyl-1-[2-thienyl]ethyl-4-piperidinyl)-N-phenylpro- panamide].</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(36)">(36)</span> Morpheridine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(37)">(37)</span> MPPP (1-methyl-4-phenyl-4-propionoxypiperidine).</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(38)">(38)</span> Noracymethadol.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(39)">(39)</span> Norlevorphanol.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(40)">(40)</span> Normethadone.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(41)">(41)</span> Norpipanone.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(42)">(42)</span> Para-fluorofentanyl [N-(4-fluorophenyl)-N-(1-[2-phenethyl]-4-piperidinyl) propan- amide].</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(43)">(43)</span> PEPAP[1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine].</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(44)">(44)</span> Phenadoxone.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(45)">(45)</span> Phenampromide.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(46)">(46)</span> Phenomorphan.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(47)">(47)</span> Phenoperidine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(48)">(48)</span> Piritramide.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(49)">(49)</span> Proheptazine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(50)">(50)</span> Properidine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(51)">(51)</span> Propiram.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(52)">(52)</span> Racemoramide.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(53)">(53)</span> Thiofentanyl [N-phenyl-N-(1-[2-thienyl]ethyl-4-piperidinyl)-propanamide].</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(54)">(54)</span> Tilidine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(55)">(55)</span> Trimeperidine.</p>
                <p class="text-indent-1 "><span class="level-num" id="B.">B.</span> Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(1)">(1)</span> Acetorphine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(2)">(2)</span> Acetyldihydrocodeine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(3)">(3)</span> Benzylmorphine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(4)">(4)</span> Codeine methylbromide.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(5)">(5)</span> Codeine-N-Oxide.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(6)">(6)</span> Cyprenorphine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(7)">(7)</span> Desomorphine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(8)">(8)</span> Dihydromorphine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(9)">(9)</span> Drotebanol.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(10)">(10)</span> Etorphine (except hydrochloride salt).</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(11)">(11)</span> Heroin.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(12)">(12)</span> Hydromorphinol.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(13)">(13)</span> Methyldesorphine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(14)">(14)</span> Methyldihydromorphine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(15)">(15)</span> Morphine methylbromide.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(16)">(16)</span> Morphine methylsulfonate.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(17)">(17)</span> Morphine-N-Oxide.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(18)">(18)</span> Myrophine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(19)">(19)</span> Nicocodeine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(20)">(20)</span> Nicomorphine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(21)">(21)</span> Normorphine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(22)">(22)</span> Pholcodine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(23)">(23)</span> Thebacon.</p>
                <p class="text-indent-1 "><span class="level-num" id="C.">C.</span> Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (For purposes of this subsection only, the term "isomer" includes the optical, position and geometric isomers.):</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(1)">(1)</span> Alpha-ethyltryptamine [some trade or other names: etryptamine; Monase; α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET].</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(2)">(2)</span> 4-bromo-2,5-dimethoxy-amphetamine (some trade or other names: 4-bromo-2, 5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA).</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(3)">(3)</span> 4-Bromo-2,5-dimethoxyphenethylamine  [some  trade  or  other  names:  2-(4-bromo-2, 5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus].</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(4)">(4)</span> 2,5-dimethoxyamphetamine (some trade or other names: 2,5-dimethoxy-α-methylphenethylamine; 2,5-DMA).</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(5)">(5)</span> 2,5-dimethoxy-4-ethylamphet-amine (some trade or other names: DOET).</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(6)">(6)</span> 2,5-dimethoxy-4-(n)-propylthiophenethylamine (some trade or other names: 2C-T-7).</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(7)">(7)</span> 4-methoxyamphetamine (some trade or other names: 4-methoxy-α- methylphenethylamine; paramethoxyamphetamine, PMA).</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(8)">(8)</span> 5-methoxy-3,4-methylenedioxy-amphetamine.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(9)">(9)</span> 4-methyl-2,5-dimethoxy-amphetamine (some trade and other names: 4-methyl-2,5-dimethoxy-α-methylphenethylamine; "DOM"; and "STP").</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(10)">(10)</span> 3,4-methylenedioxy amphetamine.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(11)">(11)</span> 3,4-methylenedioxymethamphetamine (MDMA).</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(12)">(12)</span> 3,4-methylenedioxy-N-ethylamphetamine [also known as N-ethyl-alpha-methyl-3,4 (methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA].</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(13)">(13)</span> N-hydroxy-3,4-methylenedioxyamphetamine [also known as N-hydroxy-alpha -methyl-3, 4(methylenedioxy)phenethylamine, and N-hydroxy MDA].</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(14)">(14)</span> 3,4,5-trimethoxy amphetamine.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(15)">(15)</span> 5-methoxy-N,N-dimethyltryptamine  [some  trade  or  other  names:  5-methoxy-3-(2-[dimethylamino]ethyl) indole; 5-MeO-DMT].</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(16)">(16)</span> Alpha-methyltryptamine (other name: AMT).</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(17)">(17)</span> Bufotenine [some trade and other names: 3-(β-Dimethylaminoethyl) -5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol;	N,N-dimethylserotonin;	5-hydroxy-N,N-dimethyltryptamine; mappine].</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(18)">(18)</span> Diethyltryptamine (some trade and other names: N,N-Diethyltryptamine; DET).</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(19)">(19)</span> Dimethyltryptamine (some trade or other names: DMT).</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(20)">(20)</span> 5-methoxy-N, N-diisopropyltryptamine (other name: 5-MeO-DIPT).</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(21)">(21)</span> Ibogaine  [some  trade  and  other  names:  7-Ethyl-6;6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido (1', 2':1,2) azepino (5,4-b) indole; Tabernanthe iboga].</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(22)">(22)</span> Lysergic acid diethylamide.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(23)">(23)</span> Marijuana, also marihuana.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(24)">(24)</span> Mescaline.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(25)">(25)</span> Parahexyl;  some  trade  or  other  names:  3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6, 6,9-trimethyl-6H-dibenzo(b,d)pyran; Synhexyl.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(26)">(26)</span> Peyote: meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts. (A religious exception is found in § 306-11.)</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(27)">(27)</span> N-ethyl-3-piperidyl benzilate.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(28)">(28)</span> N-methyl-3-piperidyl benzilate.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(29)">(29)</span> Psilocybin.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(30)">(30)</span> Psilocyn.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(31)">(31)</span> Tetrahydrocannabinols: meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(a)">(a)</span> 1 cis or trans tetrahydrocannabinol, and their optical isomers.</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(b)">(b)</span> 6 cis or trans tetrahydrocannabinol, and their optical isomers.</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(c)">(c)</span> 3,4 cis or trans tetrahydrocannabinol, and its optical isomers.</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(d)">(d)</span> (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.)</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(e)">(e)</span> Ethylamine  analog  of  phencyclidine  [some  trade  or  other  names:  N-ethyl-1-phenylcyclohexylamine,	(1-phenylcyclohexyl)ethylamine,	N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE].</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(f)">(f)</span> Pyrrolidine analog of phencyclidine [some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP].</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(g)">(g)</span> Thiophene analog of phencyclidine [some trade or other names: 1-(1-[2-thienyl]-cyclohexyl)-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP].</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(h)">(h)</span> 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (some other names: TCPy).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(i)">(i)</span> 4-methylmethcathinone (Mephedrone).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(j)">(j)</span> 3,4-methylenedioxypyrovalerone (MDPV).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(k)">(k)</span> 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(l)">(l)</span> 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(m)">(m)</span> 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(n)">(n)</span> 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(o)">(o)</span> 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(p)">(p)</span> 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(q)">(q)</span> 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(r)">(r)</span> 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).</p>
                <p class="text-indent-3 "><span class="level-num" id="C.(31)(s)">(s)</span> 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).</p>
                <p class="text-indent-1 "><span class="level-num" id="D.">D.</span> Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.</p>
                <p class="text-indent-2 "><span class="level-num" id="D.(1)">(1)</span> The term "cannabimimetic agents" means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(1)(a)">(a)</span> 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(1)(b)">(b)</span> 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(1)(c)">(c)</span> 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(1)(d)">(d)</span> 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(1)(e)">(e)</span> 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.</p>
                <p class="text-indent-2 "><span class="level-num" id="D.(2)">(2)</span> Such term includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(a)">(a)</span> 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(b)">(b)</span> 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homo1og);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(c)">(c)</span> 1 -pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(d)">(d)</span> (6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl- 3-(2-methyloctan-2-yl)-6a, 7,10,10a-tetrahydrobenzo [c]chromen- 1-ol (HU-210);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(e)">(e)</span> 1-butyl-3-(1-naphthoyl)indole (JWH-073);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(f)">(f)</span> 1-hexyl-3-(1-naphthoyl)indole (JWH-019);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(g)">(g)</span> 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(h)">(h)</span> 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(i)">(i)</span> 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(j)">(j)</span> 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(k)">(k)</span> 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(l)">(l)</span> 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(m)">(m)</span> 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(n)">(n)</span> 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(o)">(o)</span> 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(p)">(p)</span> 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203);</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(q)">(q)</span> 1-pentyl-1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144) (Some trade or other names include TCMP-018 and KM-X1.); and</p>
                <p class="text-indent-3 "><span class="level-num" id="D.(2)(r)">(r)</span> [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclo-propyl)methanone (XLR11) (Some other trade names include 5-F-UR-144.).</p>
                <p class="text-indent-1 "><span class="level-num" id="E.">E.</span> Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</p>
                <p class="text-indent-2 "><span class="level-num" id="E.(1)">(1)</span> Gamma-hydroxybutyric acid. (Some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate.)</p>
                <p class="text-indent-2 "><span class="level-num" id="E.(2)">(2)</span> Mecloqualone.</p>
                <p class="text-indent-2 "><span class="level-num" id="E.(3)">(3)</span> Methaqualone.</p>
                <p class="text-indent-1 "><span class="level-num" id="F.">F.</span> Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(1)">(1)</span> Aminorex  (some  other  names:  aminoxaphen;  2-amino-5-phenyl-2-oxazoline;  or 4,5-dihydro-5-phenly-2-oxazolamine).</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(2)">(2)</span> N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine).</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(3)">(3)</span> Cathinone (some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone).</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(4)">(4)</span> Fenethylline.</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(5)">(5)</span> Methcathinone [some other names: 2-(methylamino)-propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432], its salts, optical isomers and salts of optical isomers.</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(6)">(6)</span> (±)cis-4-methylaminorex [(±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine].</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(7)">(7)</span> N-ethylamphetamine.</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(8)">(8)</span> N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl- benzeneethanamine; N,N-alpha-trimethylphenethylamine).</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__menominee-nsn" aria-label="Previous and next article links">
            <section>
              <a href="/us/nsn/menominee/legislature/code/II/306-5" aria-label="§ 306-5 Scheduling of controlled substances.">
                <div class="h__ui">Previous</div>
                <span>§ 306-5 Scheduling of controlled substances.</span>
              </a>
            </section>
            <section>
              <a href="/us/nsn/menominee/legislature/code/II/306-7" aria-label="§ 306-7 Schedule II.">
                <div class="h__ui">Next</div>
                <span>§ 306-7 Schedule II.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__menominee-nsn">
        <div id="section__footer__inner" class="ns__document__menominee-nsn">
          <div id="area__footer__content" class="ns__document__menominee-nsn">
            <p>The codes and laws on this website are in the public domain.</p>
            <p>
      Please do not scrape. Instead, bulk download the <a href="https://github.com/menominee-nsn/law-html">HTML</a> or <a href="https://github.com/menominee-nsn/law-xml">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p>
          </div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
